Home LiteratureArticle Details
PMID: 15717949 Published · ppublish English Journal Article Review

Prevention of head and neck cancer.

Current oncology reports ·Vol. 7 ·No. 2 ·2005-03-00 ·Pages 145-53

Day TA, Chi A, Neville B, Hebert JR

Abstract

In the vast majority of cases, head and neck cancer is a preventable disease. The relationship between tobacco and alcohol and these cancers is well established. Despite efforts aimed at reduction of risk factor exposure and early detection methods, head and neck cancer remains one of the more common cancers worldwide. Recent advances in molecular techniques have provided a framework for future targets for early diagnosis and treatment of these malignancies. This review provides a summary of recent developments in primary and secondary prevention of head and neck cancer and innovative strategies aimed at a reduction in incidence and mortality from this disease. The future prevention of head and neck cancer will likely require solutions to the widespread use of tobacco products and innovative diagnostic techniques leading to improvements in overall survival.

MeSH Terms
Alcohol Drinking/adverse effects Anticarcinogenic Agents/therapeutic use Carcinoma, Squamous Cell/prevention & control Head and Neck Neoplasms/etiology,genetics,prevention & control Health Education Humans Risk Factors Smoking/adverse effects
Chemicals
Anticarcinogenic Agents
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Day Terry A
Head and Neck Tumor Program, Hollings Cancer Center, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA. dayt@musc.edu
Chi Angela
Neville Brad
Hebert James R
References (81)
81 references, click to expand
  1. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer.
    Oral Oncol. 2001 Jan;37(1):94-8 PMID: 11120489
  2. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer.
    Eur J Cancer Prev. 2004 Feb;13(1):39-45 PMID: 15075787
  3. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):739-47 PMID: 11849797
  4. Cyclooxygenase inhibition as a target for prevention of tobacco-related cancers.
    Clin Cancer Res. 2004 Mar 1;10(5):1557-8 PMID: 15014002
  5. A causal role for human papillomavirus in head and neck cancer.
    Lancet. 2004 May 8;363(9420):1488-9 PMID: 15135592
  6. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Oncogene. 1997 Nov 27;15(22):2667-74 PMID: 9400993
  7. Oral cancer information in health education textbooks.
    J Cancer Educ. 2004 Spring;19(1):12-6 PMID: 15059751
  8. Lichen planus and oral cancer: is there a connection between the two?
    J Am Dent Assoc. 1992 May;123(5):104-8 PMID: 1597633
  9. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.
    J Am Dent Assoc. 1999 Oct;130(10):1445-57 PMID: 10570588
  10. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Cancer Res. 1997 Mar 1;57(5):963-9 PMID: 9041202
  11. Oral lichen planus: the evidence regarding potential malignant transformation.
    J Oral Pathol. 1978 Feb;7(1):1-7 PMID: 418159
  12. Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma.
    Acta Otolaryngol. 1990 Sep-Oct;110(3-4):309-13 PMID: 2239223
  13. Diet and nutrition in the etiology of oral cancer.
    Am J Clin Nutr. 1995 Feb;61(2):437S-445S PMID: 7840089
  14. News media coverage of smoking and health is associated with changes in population rates of smoking cessation but not initiation.
    Tob Control. 2001 Jun;10(2):145-53 PMID: 11387535
  15. Estimates of the worldwide incidence of 25 major cancers in 1990.
    Int J Cancer. 1999 Mar 15;80(6):827-41 PMID: 10074914
  16. Coverage and quality of oral cancer information in the popular press: 1987-98.
    J Public Health Dent. 1998 Summer;58(3):241-7 PMID: 10101701
  17. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):83-91 PMID: 10550831
  18. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    J Clin Oncol. 2001 Jun 15;19(12):3010-7 PMID: 11408495
  19. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele.
    J Natl Cancer Inst. 1996 Oct 16;88(20):1489-91 PMID: 8841025
  20. Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck.
    Cancer Immunol Immunother. 2004 May;53(5):375-82 PMID: 14634795
  21. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group.
    Oncol Rep. 2004 Jun;11(6):1297-305 PMID: 15138569
  22. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
    Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1043-9 PMID: 11045786
  23. Smokeless tobacco and cancer: the epidemiologic evidence.
    CA Cancer J Clin. 1988 Jul-Aug;38(4):236-43 PMID: 3135083
  24. Tobacco use and oral cancer: a global perspective.
    J Dent Educ. 2001 Apr;65(4):328-39 PMID: 11336118
  25. Alcohol--the neglected risk factor in head and neck cancer.
    Clin Otolaryngol Allied Sci. 2004 Aug;29(4):295-300 PMID: 15270811
  26. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
    Arch Otolaryngol Head Neck Surg. 1995 Jul;121(7):790-4 PMID: 7598859
  27. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.
    Laryngoscope. 1996 Aug;106(8):972-6 PMID: 8699911
  28. An analysis of risk factors for oral cancer in young people: a case-control study.
    Oral Oncol. 2004 Mar;40(3):304-13 PMID: 14747062
  29. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases.
    Anal Cell Pathol. 2003;25(4):159-66 PMID: 14501082
  30. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Arch Otolaryngol Head Neck Surg. 1997 May;123(5):497-502 PMID: 9158396
  31. Effects of gastroesophageal reflux disease in laryngeal carcinoma.
    Clin Otolaryngol Allied Sci. 2004 Oct;29(5):545-8 PMID: 15373871
  32. An assessment of oral cancer prevention curricula in U.S. medical schools.
    J Cancer Educ. 1998 Summer;13(2):90-5 PMID: 9659627
  33. Trends in lip cancer incidence in Vaud, Switzerland.
    Br J Cancer. 1993 Nov;68(5):1012-3 PMID: 8217589
  34. Clinical characteristics and diagnostic delay of head and neck cancer: results from a prospective study in Belgium.
    Eur J Surg Oncol. 1996 Aug;22(4):354-8 PMID: 8783651
  35. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers.
    Ann Intern Med. 1993 Sep 1;119(5):383-90 PMID: 8393311
  36. COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
    Cancer. 2001 Oct 1;92(7):1888-95 PMID: 11745262
  37. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer.
    Arch Otolaryngol Head Neck Surg. 2002 Mar;128(3):268-74 PMID: 11886342
  38. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Int J Oncol. 2003 Sep;23(3):577-83 PMID: 12888890
  39. The role of human papillomavirus in oral carcinogenesis.
    Crit Rev Oral Biol Med. 2004 Jul 01;15(4):188-96 PMID: 15284184
  40. Snuff dipping and oral cancer among women in the southern United States.
    N Engl J Med. 1981 Mar 26;304(13):745-9 PMID: 7193288
  41. Malignant transformation rate in oral submucous fibrosis over a 17-year period.
    Community Dent Oral Epidemiol. 1985 Dec;13(6):340-1 PMID: 3866655
  42. Smoking history and cancer patient survival: a hospital cancer registry study.
    Cancer Detect Prev. 1997;21(6):497-509 PMID: 9398990
  43. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.
    Expert Opin Biol Ther. 2001 Jul;1(4):719-32 PMID: 11727507
  44. The influence of resection and aneuploidy on mortality in oral leukoplakia.
    N Engl J Med. 2004 Apr 1;350(14):1405-13 PMID: 15070790
  45. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Head Neck. 2002 Sep;24(9):841-9 PMID: 12211048
  46. The epidemiology of lip cancer: a review of global incidence and aetiology.
    Oral Dis. 1999 Jul;5(3):185-95 PMID: 10483063
  47. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India.
    Oral Oncol. 2003 Sep;39(6):580-8 PMID: 12798401
  48. Smoking and drinking in relation to oral and pharyngeal cancer.
    Cancer Res. 1988 Jun 1;48(11):3282-7 PMID: 3365707
  49. The World Cancer Report and the burden of oral cancer.
    Eur J Cancer Prev. 2004 Apr;13(2):139-42 PMID: 15100581
  50. Marijuana use and risk of oral squamous cell carcinoma.
    Cancer Res. 2004 Jun 1;64(11):4049-54 PMID: 15173020
  51. Public policy and smoking cessation among young adults in the United States.
    Health Policy. 2004 Jun;68(3):321-32 PMID: 15113643
  52. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
    Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1605-10 PMID: 12496051
  53. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
    Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1083-9 PMID: 10522499
  54. Tobacco and cancer: recent epidemiological evidence.
    J Natl Cancer Inst. 2004 Jan 21;96(2):99-106 PMID: 14734699
  55. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans.
    Cancer. 1993 Aug 15;72(4):1369-75 PMID: 8339227
  56. Survey of U.S. dentists' knowledge and opinions about oral pharyngeal cancer.
    J Am Dent Assoc. 2000 May;131(5):653-61 PMID: 10832259
  57. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.
    J Natl Cancer Inst. 1994 Jan 19;86(2):140-1 PMID: 8271298
  58. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Laryngoscope. 2002 Dec;112(12):2129-40 PMID: 12461330
  59. Carcinoma of the lip in kidney transplant recipients.
    J Am Acad Dermatol. 1998 Mar;38(3):497-9 PMID: 9520038
  60. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer.
    Cancer Lett. 1999 Nov 1;146(1):93-101 PMID: 10656614
  61. Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
    Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1071-8 PMID: 10613339
  62. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.
    BMJ. 1996 Sep 21;313(7059):716-21 PMID: 8819440
  63. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit.
    Oral Oncol. 2004 Sep;40(8):829-34 PMID: 15288839
  64. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study.
    Int J Cancer. 1995 Dec 11;63(6):769-73 PMID: 8847131
  65. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9 PMID: 11489748
  66. Genetic progression model for head and neck cancer: implications for field cancerization.
    Cancer Res. 1996 Jun 1;56(11):2488-92 PMID: 8653682
  67. Symptoms as an index of biologic behavior in head and neck cancer.
    Otolaryngol Head Neck Surg. 1999 Mar;120(3):380-6 PMID: 10064642
  68. Molecular genetics of head and neck cancer.
    Cancer Control. 2002 Sep-Oct;9(5):369-78 PMID: 12410176
  69. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal.
    Curr Opin Oncol. 2000 May;12(3):240-5 PMID: 10841196
  70. Alcohol metabolism: role in toxicity and carcinogenesis.
    Alcohol Clin Exp Res. 2003 Feb;27(2):336-47 PMID: 12605083
  71. [Squamous cell carcinoma of the ENT organs in the course of the HIV infection].
    Ann Otolaryngol Chir Cervicofac. 1999 Jun;116(3):149-53 PMID: 10399530
  72. U.S. adult knowledge of risk factors and signs of oral cancers: 1990.
    J Am Dent Assoc. 1995 Jan;126(1):39-45 PMID: 7822644
  73. Chemoprevention of cancer.
    CA Cancer J Clin. 2004 May-Jun;54(3):150-80 PMID: 15195789
  74. Intraoral squamous cell carcinoma in human immunodeficiency virus infection. A clinicopathologic study.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jul;80(1):55-62 PMID: 7552863
  75. Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome.
    Anticancer Res. 2004 May-Jun;24(3b):1829-35 PMID: 15274363
  76. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
    J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83 PMID: 14652239
  77. The presenting symptoms of head and neck cancer.
    N Z Med J. 1982 May 26;95(708):337-41 PMID: 6954395
  78. Keeping the focus on public health: the struggles of a tobacco prevention task force.
    Health Educ Behav. 2003 Dec;30(6):771-88 PMID: 14655869
  79. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
    Neoplasia. 2001 Jan-Feb;3(1):53-61 PMID: 11326316
  80. Maryland dental hygienists' views of oral cancer prevention and early detection.
    J Dent Hyg. 2002 Summer;76(3):186-91 PMID: 12271863
  81. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Laryngoscope. 2002 Sep;112(9):1587-93 PMID: 12352668
Article Info
Journal
Current oncology reports
Abbr.
Curr Oncol Rep
ISSN
1523-3790
DOI
10.1007/s11912-005-0041-x
Email
dayt@musc.edu
Published
2005-03-00
Pages
145-53
Language
English
Region
United States
NLM ID
100888967
Subset
IM
External Links
PubMed source DOI: 10.1007/s11912-005-0041-x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2